RATIONALE 001: Tislelizumab (BGB-A317) + concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC)

Locally Advanced ◽

Small Cell ◽

Stage Iii ◽

Newly Diagnosed ◽

Small Cell Lung ◽

Consolidation chwemotherapy after concurrent chemoradiotherapy vs. chemoradiotherapy alone for locally advanced unresectable stage III non-small-cell lung cancer: A meta-analysis

Molecular and Clinical Oncology ◽

10.3892/mco.2016.910 ◽

2016 ◽

Vol 5 (2) ◽

pp. 271-278 ◽

Cited By ~ 3

Author(s):

Xiu-Jun Chang ◽

Zi-Tong Wang ◽

Lei Yang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Locally Advanced ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients with Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC)

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.05.009 ◽

2021 ◽

Author(s):

Mark A. Socinski ◽

Mustafa Özgüroğlu ◽

Augusto Villegas ◽

Davey Daniel ◽

David Vicente ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

120P Optimal chemotherapy regimen for concurrent chemo-radiotherapy of locally advanced unresectable stage III non-small cell lung cancer (NCSLC)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(18)30394-0 ◽

2018 ◽

Vol 13 (4) ◽

pp. S66-S67

Author(s):

N. Jokhadze ◽

I. Kiladze ◽

L. Katselashvili ◽

M. Kacharava ◽

N. Jankarashvili ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Chemotherapy Regimen ◽

Locally Advanced ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small cell lung cancer: a case report

Annals of Palliative Medicine ◽

10.21037/apm-20-1118 ◽

2020 ◽

Vol 9 (4) ◽

pp. 2375-2380 ◽

Cited By ~ 1

Author(s):

Tao Zhang ◽

Yuqi Wu ◽

Shan Zheng ◽

Guowei Cheng ◽

Xiangling He ◽

...

Keyword(s):

Lung Cancer ◽

Case Report ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

1255TiP CheckMate 73L: A phase III study comparing nivolumab (NIVO) plus concurrent chemoradiotherapy (CCRT) followed by NIVO ± ipilimumab (IPI) versus CCRT followed by durvalumab (DURV) for previously untreated, locally advanced (LA) stage III non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.128 ◽

2020 ◽

Vol 31 ◽

pp. S810

Author(s):

D. De Ruysscher ◽

S.S. Ramalingam ◽

J. Urbanic ◽

D.E. Gerber ◽

D.S.W. Tan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Phase Iii ◽

Stage Iii ◽

Small Cell Lung ◽

Phase Iii Study

Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(05)81569-7 ◽

2005 ◽

Vol 50 ◽

pp. S17-S24 ◽

Cited By ~ 13

Author(s):

James R. Rigas ◽

Primo N. Lara

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Treatment Strategies ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

The Influence of Pulmonary Diffusion Impairment on Prognosis of Unresectable Stage III Non-Small Cell Lung Cancer Patients Who Received Concurrent Chemoradiotherapy

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5550 ◽

2019 ◽

Author(s):

T. Tozuka ◽

M. Seike ◽

H. Hayashi ◽

A. Miyanaga ◽

Y. Minegishi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Sequential chemoradiotherapy versus concurrent chemoradiotherapy plus consolidation chemotherapy in unresectable stage III non-small cell lung cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.18509 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 18509-18509

Author(s):

H. M. El-Shenshawy ◽

A. Fathy ◽

S. Eteba

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Consolidation Chemotherapy ◽

CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.07.005 ◽

2021 ◽

Author(s):

Dirk De Ruysscher ◽

Suresh Ramalingam ◽

James Urbanic ◽

David E Gerber ◽

Daniel S.-W. Tan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Stage Iii ◽

Advanced Stage ◽

Small Cell Lung ◽

Phase 3

Concurrent Chemoradiotherapy for Unresectable Stage III Non-Small Cell Lung Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-05-9008 ◽

2005 ◽

Vol 11 (13) ◽

pp. 5045s-5050s ◽

Cited By ~ 24

Author(s):

E. E. Vokes

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽